Clinical Trial Update: Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon [Phase 2, Phase 3]

View source ↗

Summary

The update summarizes results from Phase 2/3 trials examining acyclovir to suppress HIV-1 and HSV-2 coinfection in Cameroon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Simplex Virus Type Infection

Drugs mentioned

• ACYCLOVIR (Acyclovir)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: HIV-1 and HSV-2 Coinfection, HIV Infections | Phase 2, Phase 3 | Status: COMPLETED